Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Revenue (2018 - 2025)

Neurogene (NGNE) has disclosed Revenue for 5 consecutive years, with -$1000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Revenue rose 99.81% year-over-year to -$1000.0, compared with a TTM value of -$81000.0 through Sep 2025, up 92.86%, and an annual FY2024 reading of $925000.0, up 3403.57% over the prior year.
  • Revenue was -$1000.0 for Q2 2025 at Neurogene, up from -$80000.0 in the prior quarter.
  • Across five years, Revenue topped out at -$1000.0 in Q2 2025 and bottomed at -$602000.0 in Q1 2024.